Freeze drier capacity

Since we are here concerned mainly with pharmaceutical and, especially, biopharmaceutical freeze-drying, processing costs are of secondary importance. Care must however be taken that limited freeze-drying capacity does not give rise to production problems. Thus, where the total drier capacity threatens to become the limiting factor in the production cycle, the best remedy is to examine whether, and how the cycle length might be reduced, commensurate with the maintenance of an acceptable product quality. This is a problem to which we shall return several times. 

---